Ribeiro RM - Search Results

1

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody.

Phan T, Zitzmann C, Chew KW, Smith DM, Daar ES, Wohl DA, Eron JJ, Currier JS, Hughes MD, Choudhary MC, Deo R, Li JZ, Ribeiro RM, Ke R, Perelson AS; ACTIV-2/A5401 Study Team. Phan T, et al. Among authors: ribeiro rm. bioRxiv [Preprint]. 2023 Sep 17:2023.09.14.557679. doi: 10.1101/2023.09.14.557679. bioRxiv. 2023. Update in: PLoS Pathog. 2024 Apr 18;20(4):e1011680. doi: 10.1371/journal.ppat.1011680. PMID: 37745410 Free PMC article. Updated. Preprint.

2

Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed.

Lewin SR, Ribeiro RM, Walters T, Lau GK, Bowden S, Locarnini S, Perelson AS. Lewin SR, et al. Among authors: ribeiro rm. Hepatology. 2001 Nov;34(5):1012-20. doi: 10.1053/jhep.2001.28509. Hepatology. 2001. PMID: 11679973

3

Modeling deuterated glucose labeling of T-lymphocytes.

Ribeiro RM, Mohri H, Ho DD, Perelson AS. Ribeiro RM, et al. Bull Math Biol. 2002 Mar;64(2):385-405. doi: 10.1006/bulm.2001.0282. Bull Math Biol. 2002. PMID: 11926122

4

Hepatitis B virus viral dynamics: effects of drug dose and baseline alanine aminotransferase.

Ribeiro RM, Perelson AS. Ribeiro RM, et al. J Hepatol. 2002 Aug;37(2):277-9. doi: 10.1016/s0168-8278(02)00210-6. J Hepatol. 2002. PMID: 12127436 Review. No abstract available.

5

Dynamics of hepatitis B virus infection.

Ribeiro RM, Lo A, Perelson AS. Ribeiro RM, et al. Microbes Infect. 2002 Jul;4(8):829-35. doi: 10.1016/s1286-4579(02)01603-9. Microbes Infect. 2002. PMID: 12270730 Free article. Review.

6

In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?

Ribeiro RM, Mohri H, Ho DD, Perelson AS. Ribeiro RM, et al. Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15572-7. doi: 10.1073/pnas.242358099. Epub 2002 Nov 14. Proc Natl Acad Sci U S A. 2002. PMID: 12434018 Free PMC article.

7

Mathematical modeling of viral kinetics: a tool to understand and optimize therapy.

Layden TJ, Layden JE, Ribeiro RM, Perelson AS. Layden TJ, et al. Among authors: ribeiro rm. Clin Liver Dis. 2003 Feb;7(1):163-78. doi: 10.1016/s1089-3261(02)00063-6. Clin Liver Dis. 2003. PMID: 12691465 Review.

8

Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin.

Layden-Almer JE, Ribeiro RM, Wiley T, Perelson AS, Layden TJ. Layden-Almer JE, et al. Among authors: ribeiro rm. Hepatology. 2003 Jun;37(6):1343-50. doi: 10.1053/jhep.2003.50217. Hepatology. 2003. PMID: 12774013

9

Dynamics of alanine aminotransferase during hepatitis C virus treatment.

Ribeiro RM, Layden-Almer J, Powers KA, Layden TJ, Perelson AS. Ribeiro RM, et al. Hepatology. 2003 Aug;38(2):509-17. doi: 10.1053/jhep.2003.50344. Hepatology. 2003. PMID: 12883496

10

Modeling viral and drug kinetics: hepatitis C virus treatment with pegylated interferon alfa-2b.

Powers KA, Dixit NM, Ribeiro RM, Golia P, Talal AH, Perelson AS. Powers KA, et al. Among authors: ribeiro rm. Semin Liver Dis. 2003;23 Suppl 1:13-8. doi: 10.1055/s-2003-41630. Semin Liver Dis. 2003. PMID: 12934163 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters